Cambridge Nutritional Sciences plc (FRA:RVKA)
Germany
· Delayed Price · Currency is EUR 0.0155
-0.0015 (-8.82%)
At close: Dec 4, 2025
FRA:RVKA Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 8.06 | 8.33 | 9.77 | 7.55 | 8.54 | 6.82 | Upgrade
|
| Revenue Growth (YoY) | -10.20% | -14.77% | 29.53% | -11.63% | 25.28% | -30.58% | Upgrade
|
| Cost of Revenue | 2.71 | 2.89 | 3.73 | 4 | 3.44 | 2.82 | Upgrade
|
| Gross Profit | 5.35 | 5.44 | 6.05 | 3.55 | 5.1 | 4 | Upgrade
|
| Selling, General & Admin | 6.24 | 6.12 | 6.67 | 6.29 | 5.69 | 4.62 | Upgrade
|
| Other Operating Expenses | -0.35 | -0.28 | -0.08 | -0.03 | - | -0.15 | Upgrade
|
| Operating Expenses | 5.89 | 5.84 | 6.58 | 6.26 | 5.69 | 4.46 | Upgrade
|
| Operating Income | -0.54 | -0.4 | -0.54 | -2.72 | -0.59 | -0.47 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.08 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.15 | 0.05 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.45 | -0.27 | -0.51 | -2.73 | -0.61 | -0.55 | Upgrade
|
| Other Unusual Items | 1.81 | 1.83 | -0.24 | -0.52 | -0.34 | - | Upgrade
|
| Pretax Income | 1.37 | 1.57 | -0.75 | -3.25 | -0.95 | -0.55 | Upgrade
|
| Income Tax Expense | - | - | -0.42 | -0.08 | 0.46 | -0.93 | Upgrade
|
| Earnings From Continuing Operations | 1.37 | 1.57 | -0.33 | -3.17 | -1.41 | 0.39 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -0.69 | -9.92 | -2.49 | Upgrade
|
| Net Income | 1.37 | 1.57 | -0.33 | -3.86 | -11.33 | -2.1 | Upgrade
|
| Net Income to Common | 1.37 | 1.57 | -0.33 | -3.86 | -11.33 | -2.1 | Upgrade
|
| Net Income Growth | 684.48% | - | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 238 | 238 | 238 | 231 | 183 | 172 | Upgrade
|
| Shares Outstanding (Diluted) | 238 | 238 | 238 | 232 | 187 | 177 | Upgrade
|
| Shares Change (YoY) | 0.08% | 0.07% | 2.70% | 23.98% | 5.59% | 26.20% | Upgrade
|
| EPS (Basic) | 0.01 | 0.01 | -0.00 | -0.02 | -0.06 | -0.01 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.01 | -0.00 | -0.02 | -0.06 | -0.01 | Upgrade
|
| EPS Growth | 684.13% | - | - | - | - | - | Upgrade
|
| Free Cash Flow | -0.54 | -0.28 | 0.56 | -3.18 | -4.2 | -4.38 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.00 | -0.01 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | 66.44% | 65.32% | 61.86% | 46.98% | 59.75% | 58.63% | Upgrade
|
| Operating Margin | -6.70% | -4.74% | -5.47% | -35.98% | -6.93% | -6.87% | Upgrade
|
| Profit Margin | 16.94% | 18.80% | -3.36% | -51.15% | -132.72% | -30.87% | Upgrade
|
| Free Cash Flow Margin | -6.71% | -3.38% | 5.72% | -42.10% | -49.15% | -64.32% | Upgrade
|
| EBITDA | -0.33 | -0.2 | -0.2 | -2.39 | -0.05 | -0.1 | Upgrade
|
| EBITDA Margin | -4.04% | -2.35% | -2.05% | -31.63% | -0.61% | -1.48% | Upgrade
|
| D&A For EBITDA | 0.21 | 0.2 | 0.34 | 0.33 | 0.54 | 0.37 | Upgrade
|
| EBIT | -0.54 | -0.4 | -0.54 | -2.72 | -0.59 | -0.47 | Upgrade
|
| EBIT Margin | -6.70% | -4.74% | -5.47% | -35.98% | -6.93% | -6.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.